We further examined the efficacy of this newly developed strategy for the inhibition of FAK and PYK2, by exploring the impact of LD2-LD4 expression on tumor growth and metastasis in vivo, using a highly metastatic breast cancer xenograft model. The gene discussed is PTK2B; the disease is breast cancer.